Literature DB >> 18259815

Sacral nerve stimulation can improve continence in patients with Crohn's disease with internal and external anal sphincter disruption.

Véronique Vitton1, Julie Gigout, Jean-Charles Grimaud, Michel Bouvier, Ariadne Desjeux, Pierre Orsoni.   

Abstract

PURPOSE: Sacral nerve stimulation is a technique commonly used for the treatment of idiopathic incontinence. This study was designed to assess the efficiency of sacral nerve stimulation as a means of treating fecal incontinence in patients with Crohn's disease with disrupted internal and external anal sphincters.
METHODS: Five patients (3 women) with fecal incontinence suffering from Crohn's disease-related anoperineal lesions were treated by applying three weeks of sacral nerve stimulation and then by permanent sacral nerve stimulation implantation. Endoanal ultrasonography showed that all of these patients had disrupted external and internal anal sphincters.
RESULTS: Continence was improved in all treated patients. The median follow-up time was 14 (range, 3-36) months. At the end of the follow-up period, the median Wexner's score significantly improved from 15 to 6 and the median number of daily stools decreased from 7 to 2. The patients' quality of life also increased significantly.
CONCLUSIONS: Sacral nerve stimulation improves fecal continence in patients suffering from Crohn's anoperineal lesions with internal and external anal sphincters disruption.

Entities:  

Mesh:

Year:  2008        PMID: 18259815     DOI: 10.1007/s10350-008-9209-4

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  10 in total

1.  Meta-analysis: sacral nerve stimulation versus conservative therapy in the treatment of faecal incontinence.

Authors:  Emile Tan; Nye-Thane Ngo; Ara Darzi; Michael Shenouda; Paris P Tekkis
Journal:  Int J Colorectal Dis       Date:  2011-01-29       Impact factor: 2.571

Review 2.  Sacral neuromodulation stimulation in fecal incontinence.

Authors:  Tracy L Hull
Journal:  Int Urogynecol J       Date:  2010-12       Impact factor: 2.894

Review 3.  Faecal incontinence: Current knowledges and perspectives.

Authors:  Alban Benezech; Michel Bouvier; Véronique Vitton
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 4.  Current status: new technologies for the treatment of patients with fecal incontinence.

Authors:  Andreas M Kaiser; Guy R Orangio; Massarat Zutshi; Suraj Alva; Tracy L Hull; Peter W Marcello; David A Margolin; Janice F Rafferty; W Donald Buie; Steven D Wexner
Journal:  Surg Endosc       Date:  2014-03-08       Impact factor: 4.584

5.  Is sacral neuromodulation here to stay? Clinical outcomes of a new treatment for fecal incontinence.

Authors:  Bobby L Johnson; Adam Abodeely; Martha A Ferguson; Bradley R Davis; Janice F Rafferty; Ian M Paquette
Journal:  J Gastrointest Surg       Date:  2014-08-13       Impact factor: 3.452

Review 6.  Posterior tibial nerve stimulation and faecal incontinence: a review.

Authors:  John M Findlay; Charles Maxwell-Armstrong
Journal:  Int J Colorectal Dis       Date:  2010-11-11       Impact factor: 2.571

7.  Sacral neuromodulation for bowel dysfunction: a consensus statement from the Italian group.

Authors:  E Falletto; E Ganio; G Naldini; C Ratto; D F Altomare
Journal:  Tech Coloproctol       Date:  2013-04-06       Impact factor: 3.781

8.  Sacral neuromodulation and peripheral nerve stimulation in patients with anal incontinence: an overview of techniques, complications and troubleshooting.

Authors:  Andrew P Zbar
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-04-10

Review 9.  Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.

Authors:  Luísa Leite Barros; Alberto Queiroz Farias; Ali Rezaie
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

Review 10.  Inflammatory Bowel Disease Nurse-Practical Messages.

Authors:  Chiara Rosso; Alami Aroussi Aaron; Angelo Armandi; Gian Paolo Caviglia; Marta Vernero; Giorgio Maria Saracco; Marco Astegiano; Elisabetta Bugianesi; Davide Giuseppe Ribaldone
Journal:  Nurs Rep       Date:  2021-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.